Professor Peter Sleight

Professor Peter Sleight's AcademicInfluence.com Rankings

Medical

#828

World Rank

#1083

Historical Rank

Cardiology

#40

World Rank

#40

Historical Rank

medical Degrees

Download Badge

Medical

Why Is Professor Peter Sleight Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Professor Peter Sleight's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. (2000) (7520)
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). (2013) (6036)
2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). (2007) (5476)
Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients (1994) (3667)
Telmisartan, ramipril, or both in patients at high risk for vascular events. (2008) (3342)
Beta blockade during and after myocardial infarction: an overview of the randomized trials. (1985) (3268)
Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. (1988) (2755)
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial (2011) (2093)
ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction (1995) (1755)
Vitamin E supplementation and cardiovascular events in high-risk patients. (2000) (1606)
Reflex Regulation of Arterial Pressure during Sleep in Man: A Quantitative Method of Assessing Baroreflex Sensitivity (1969) (1314)
Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. (2005) (1119)
2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. (2013) (1115)
Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions (2004) (1066)
MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial (2002) (1021)
Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials (2015) (999)
The task force for the management ofarterial hypertension of the european society ofhypertension (esh) and of the european society of cardiology (esc) (2013) (991)
Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial (2000) (962)
Controlled Trial of Physical Training in Chronic Heart Failure: Exercise Performance, Hemodynamics, Ventilation, and Autonomic Function (1992) (922)
ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION (1992) (920)
Effect of Age and High Blood Pressure on Barorefiex Sensitivity in Man (1971) (894)
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial (2008) (832)
The 2013 ESH/ESC guidelines for the management of arterial hypertension (2013) (805)
Changes in Autonomic Regulation Induced by Physical Training in Mild Hypertension (1988) (785)
2013 ESH/ESC Guidelines for the management of arterial hypertension (2013) (754)
Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. (2003) (723)
A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease (2011) (638)
Publication bias (1991) (632)
Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group. (1998) (632)
HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment (2013) (605)
Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial (2002) (582)
2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension (2014) (579)
Contribution of muscle afferents to the hemodynamic, autonomic, and ventilatory responses to exercise in patients with chronic heart failure: effects of physical training. (1996) (550)
Urinary sodium and potassium excretion and risk of cardiovascular events. (2011) (538)
Cardiovascular, cerebrovascular, and respiratory changes induced by different types of music in musicians and non-musicians: the importance of silence (2005) (515)
Human Baroreflexes in Health and Disease (1992) (505)
Effects of controlled breathing, mental activity and mental stress with or without verbalization on heart rate variability. (2000) (494)
Comparative Effects of Ramipril on Ambulatory and Office Blood Pressures: A HOPE Substudy (2001) (487)
Reduction of Cardiovascular Risk by Regression of Electrocardiographic Markers of Left Ventricular Hypertrophy by the Angiotensin-Converting Enzyme Inhibitor Ramipril (2001) (465)
Heart Protection Study (2003) (461)
Effect of rosary prayer and yoga mantras on autonomic cardiovascular rhythms: comparative study (2001) (452)
Use of ramipril in preventing stroke: double blind randomised trial (2002) (427)
ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither (1998) (422)
Effects of physical training in chronic heart failure (1990) (419)
Skeletal muscle metabolism in patients with congestive heart failure: relation to clinical severity and blood flow. (1987) (379)
Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials (2019) (377)
Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Int (2004) (363)
Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study (2009) (348)
Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial. (2010) (311)
Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure. Evidence for abnormalities unrelated to blood flow. (1988) (299)
Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction. (1997) (297)
Dynamic Interactions Between Musical, Cardiovascular, and Cerebral Rhythms in Humans (2009) (291)
Physiology and pathophysiology of heart rate and blood pressure variability in humans: is power spectral analysis largely an index of baroreflex gain? (1995) (279)
Cardiovascular and respiratory changes during sleep in normal and hypertensive subjects. (1969) (262)
ACE inhibitor use in patients with myocardial infarction. Summary of evidence from clinical trials. (1995) (255)
Effects of Autonomic Blockade on the Baroreflex in Man at Rest and During Exercise (1972) (244)
CUFF AND AMBULATORY BLOOD PRESSURE IN SUBJECTS WITH ESSENTIAL HYPERTENSION (1981) (230)
Physical activity influences heart rate variability and very-low-frequency components in Holter electrocardiograms. (1996) (229)
Abnormal awake respiratory patterns are common in chronic heart failure and may prevent evaluation of autonomic tone by measures of heart rate variability. (1997) (223)
Pulse wave velocity as a measure of blood pressure change. (1976) (222)
Blood-pressure reduction and cardiovascular risk in HOPE study (2001) (221)
Baseline Characteristics and Early Blood Pressure Control in the CONVINCE Trial (2001) (218)
Modulatory effects of respiration (2001) (215)
Experience from controlled trials of physical training in chronic heart failure. Protocol and patient factors in effectiveness in the improvement in exercise tolerance. European Heart Failure Training Group. (1998) (210)
Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial). (2008) (202)
Effects of endurance training on baroreflex sensitivity and blood pressure in borderline hypertension (1991) (199)
Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals (2011) (189)
EARLY INTRAVENOUS ATENOLOL TREATMENT IN SUSPECTED ACUTE MYOCARDIAL INFARCTION Preliminary Report of a Randomised Trial (1980) (186)
Low-frequency spontaneous fluctuations of R-R interval and blood pressure in conscious humans: a baroreceptor or central phenomenon? (1994) (183)
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis (2021) (181)
Glucose Levels Predict Hospitalization for Congestive Heart Failure in Patients at High Cardiovascular Risk (2007) (181)
Persistent peripheral vasodilation and sympathetic activity in hypotension after maximal exercise. (1993) (179)
Involvement of the baroreceptor reflexes in the changes in blood pressure with sleep and mental arousal. (1983) (177)
31P nuclear magnetic resonance evidence of abnormal skeletal muscle metabolism in patients with congestive heart failure. (1987) (176)
Pitfalls in the interpretation of spectral analysis of the heart rate variability during exercise in humans. (1995) (174)
Comparison of the reflex heart rate response to rising and falling arterial pressure in man. (1972) (174)
Reduction in infarct size, arrhythmias and chest pain by early intravenous beta blockade in suspected acute myocardial infarction. (1983) (173)
Cigarette smoking, tar yields, and non-fatal myocardial infarction : 14000 cases and 32000 controls in the United Kingdom (1995) (169)
Effect of Bicycling on the Baroreflex Regulation of Pulse Interval (1971) (169)
Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease (2004) (163)
Sleep and blood pressure. (1975) (161)
Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collab (2000) (161)
Action potentials in fibres from receptors in the epicardium and myocardium of the dog's left ventricle. (1965) (158)
MRC BHFHeart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience (1999) (156)
Erectile Dysfunction Predicts Cardiovascular Events in High-Risk Patients Receiving Telmisartan, Ramipril, or Both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONT (2010) (156)
Home telemonitoring in heart failure patients: the HHH study (Home or Hospital in Heart Failure) (2009) (154)
Routine medical management of acute myocardial infarction. Lessons from overviews of recent randomized controlled trials. (1990) (152)
Prognostic implications of baroreflex sensitivity in heart failure patients in the beta-blocking era. (2009) (151)
The entry ECG in the early diagnosis and prognostic stratification of patients with suspected acute myocardial infarction. (1984) (151)
Origin of respiratory sinus arrhythmia in conscious humans. An important role for arterial carotid baroreceptors. (1997) (149)
Specific barriers to the conduct of randomized trials (2008) (148)
Relationship Between Healthy Diet and Risk of Cardiovascular Disease Among Patients on Drug Therapies for Secondary Prevention: A Prospective Cohort Study of 31 546 High-Risk Individuals From 40 Countries (2012) (147)
The reflex regulation of arterial pressure during sleep in man. (1968) (144)
Coronary event and case fatality rates in an English population: results of the Oxford myocardial infarction incidence study (1998) (144)
Flash pulmonary oedema and bilateral renal artery stenosis: the Pickering syndrome. (2011) (142)
Neural and humoral mechanisms involved in blood pressure variability. (1984) (140)
Study rationale and design of ADVANCE: Action in diabetes and vascular disease - Preterax and diamicron MR controlled evaluation (2001) (140)
Systemic and forearm vascular resistance changes after upright bicycle exercise in man. (1989) (137)
Blood Pressure Targets Recommended by Guidelines and Incidence of Cardiovascular and Renal Events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET) (2011) (136)
The use of ambulatory blood pressure monitoring to improve the accuracy and reduce the numbers of subjects in clinical trials of antihypertensive agents. (1988) (134)
Debate: Subgroup analyses in clinical trials: fun to look at - but don't believe them! (2000) (133)
Autonomic control of skin microvessels: assessment by power spectrum of photoplethysmographic waves. (1996) (132)
Cardiovascular autonomic modulation in essential hypertension. Effect of tilting. (1994) (131)
Effects of Anesthesia on Baroreflex Control of Heart Rate in Man (1969) (127)
Rationale, design, implementation, and baseline characteristics of patients in the DIG trial: a large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure. (1996) (125)
Cognitive impairment and risk of cardiovascular events and mortality. (2012) (125)
Impulses in Slowly Conducting Vagal Fibers from Afferent Endings in the Veins, Atria, and Arteries of Dogs and Cats (1973) (125)
Arterial distensibility in normal and hypertensive man. (1979) (125)
Factors influencing blood pressure and heart rate variability in hypertensive humans. (1988) (118)
Prior blunt chest trauma may be a cause of single vessel coronary disease; hypothesis and review. (2006) (116)
The joint effects of apolipoprotein B, apolipoprotein A1, LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls† (2009) (114)
Arousal and the circadian rhythm of blood pressure. (1978) (114)
Continuous Recording of Direct Arterial Pressure and Electrocardiogram in Unrestricted Man (1972) (113)
Morning peak in the incidence of myocardial infarction: experience in the ISIS-2 trial. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. (1992) (111)
Is respiratory sinus arrhythmia a good index of cardiac vagal tone in exercise? (1996) (109)
Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease. (2004) (108)
Low Doses of Scopolamine Increase Cardiac Vagal Tone in the Acute Phase of Myocardial Infarction (1993) (106)
The influence of ambulatory blood pressure monitoring on the design and interpretation of trials in hypertension (1992) (102)
Circadian pattern of heart rate variability in chronic heart failure patients. Effects of physical training. (1995) (101)
Consequences of impaired arterial baroreflexes in essential hypertension: effects on pressor responses, plasma noradrenaline and blood pressure variability. (1988) (100)
Effects of clonidine on the baroreceptor-heart rate reflex and on single aortic baroreceptor fibre discharge. (1974) (99)
Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration. (1998) (99)
Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding (1997) (98)
Benefits, challenges, and registerability of the polypill. (2006) (96)
Value of electrocardiogram in predicting and estimating infarct size in man. (1979) (95)
Arterial baroreceptors and hypertension (1980) (94)
Characteristics of single carotid sinus baroreceptor fibers and whole nerve activity in the normotensive and the renal hypertensive dog. (1977) (94)
Ventilation in chronic heart failure: effects of physical training (1992) (93)
Direct arterial pressure, heart rate and electrocardiogram during human coitus. (1974) (93)
Reduction of ventricular arrhythmias by early intravenous atenolol in suspected acute myocardial infarction. (1983) (90)
The effect of mental arithmetic on blood pressure variability and baroreflex sensitivity in man. (1978) (90)
Rationale and design for the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) Trial. (1998) (89)
Smoking and hypertension. (1993) (89)
Comparison of different methods for assessing sympathovagal balance in chronic congestive heart failure secondary to coronary artery disease. (1992) (89)
Postexercise Hypotension Is Not Sustained in Normal and Hypertensive Humans (1991) (88)
Continuous recording of direct arterial pressure in unrestricted patients. Its role in the diagnosis and management of high blood pressure. (1975) (88)
Baroreceptors and Hypertension (1968) (87)
Direct Arterial Pressure and the Electrocardiogram in Unrestricted Patients with Angina Pectoris (1973) (86)
Near-fatal bronchospasm after oral nadolol in a young asthmatic and response to ventilation with halothane. (1981) (86)
The importance of the autonomic nervous system in health and disease. (1997) (85)
Heart rate variability in acute myocardial infarction and its association with infarct site and clinical course. (1991) (84)
Failure of plasma norepinephrine to consistently reflect sympathetic activity in humans. (1986) (81)
Protocol for a prospective collaborative overview of all current and planned randomized trials of cholesterol treatment regimens. Cholesterol Treatment Trialists' (CTT) Collaboration. (1995) (79)
Candida Endocarditis Treated with 5-Fluorocytosine (1971) (78)
Association between hemodynamic impairment and Cheyne-Stokes respiration and periodic breathing in chronic stable congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. (1999) (78)
Angiotensin II and trials of cardiovascular outcomes. (2002) (77)
A cardiovascular depressor reflex from the epicardium of the left ventricle in the dog (1964) (77)
Dual inhibition of the renin–angiotensin system in high-risk diabetes and risk for stroke and other outcomes: results of the ONTARGET trial (2013) (76)
Load dependence of changes in forearm and peripheral vascular resistance after acute leg exercise in man. (1994) (76)
EARLY REHABILITATION AFTER MYOCARDIAL INFARCTION (1981) (74)
Systolic Blood Pressure Variation and Mean Heart Rate Is Associated With Cognitive Dysfunction in Patients With High Cardiovascular Risk (2015) (74)
The variability of arterial pressure. (1978) (73)
Physical training enhances sympathetic and parasympathetic control of heart rate and peripheral vessels in chronic heart failure. (1996) (72)
The effects of hypercapnia, hypoxia and ventilation on the baroreflex regulation of the pulse interval (1971) (70)
The role of baroreflex sensitivity in post-exercise hypotension. (1985) (70)
Alcohol consumption and the risk of incident atrial fibrillation among people with cardiovascular disease (2012) (70)
Reflex control of the heart. (1979) (67)
Early intravenous atenolol treatment in suspected acute myocardial infarction. (2009) (66)
Cholesterol and total mortality: need for larger trials. (1992) (65)
Clinical value of baroreflex sensitivity (2013) (65)
Baroreflex control of stroke volume in man: an effect mediated by the vagus. (1992) (64)
Systolic and Diastolic Blood Pressure Changes in Relation With Myocardial Infarction and Stroke in Patients With Coronary Artery Disease (2015) (64)
Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol (1982) (63)
Predictors of adverse outcome among patients with hypertension and coronary artery disease. (2006) (62)
Pressor responses to laboratory stresses and daytime blood pressure variability. (1987) (62)
Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy. (2008) (60)
Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP) (2016) (60)
Comparison of the effect of different types of exercise on the baroreflex regulation of heart rate. (1972) (60)
Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis (2021) (60)
Clinical relevance of short‐term day‐time breathing disorders in chronic heart failure patients (2007) (58)
Ambulatory Blood Pressure Values in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET) (2012) (58)
1999 WHO/ISH Hypertension Guidelines--highlights & ESH update. (2001) (57)
Effects of nonpersistence with medication on outcomes in high-risk patients with cardiovascular disease. (2013) (56)
Atrial natriuretic peptide is released by dynamic exercise in man. (1986) (55)
Periodic breathing in heart failure patients: testing the hypothesis of instability of the chemoreflex loop. (2000) (53)
MRC/BHF Heart Protection Study (2002) (53)
Healthy eating and reduced risk of cognitive decline (2015) (52)
Prophylactic antibiotics for cardiac pacemaker implantation. A prospective trail. (1981) (52)
Direct arterial pressure, pulse rate, and electrocardiogram during micturition and defecation in unrestricted man. (1974) (52)
The effect of phenylephrine upon arterial pressure, carotid sinus radius and baroreflex sensitivity in the conscious greyhound. (1983) (52)
Critical assessment of diagnostic value of endomyocardial biopsy. Assessment of cardiac biopsy. (1978) (51)
Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease studie (2012) (51)
From clinical trials to clinical practice (1995) (50)
Ischemic pain relief in patients with acute myocardial infarction by intravenous atenolol. (1982) (50)
Relationship of electrocardiographic left ventricular hypertrophy to mortality and cardiovascular morbidity in high-risk patients (2003) (50)
Sympathovagal balance. (1998) (50)
SIGNIFICANT REDUCTION IN MORTALITY WITH STREPTOKINASE GIVEN 7-24 HOURS AFTER PAIN ONSET (1988) (50)
Effect of long-term therapy with ramipril in high-risk women. (2002) (49)
Action potentials from ventricular mechanoreceptors stimulated by occlusion of the coronary sinus in the dog (1972) (49)
Significance of elevated MB isoenzyme with normal creatine kinase in acute myocardial infarction. (1987) (49)
Influenza Vaccination and Major Adverse Vascular Events in High-Risk Patients (2012) (48)
The ONTARGET/TRANSCEND Trial Programme: baseline data (2005) (48)
Evaluation of antiplatelet agents in the prevention of aorto-coronary bypass occlusion. (1986) (48)
Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post‐Hoc Analysis of the GISSI‐HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca‐Heart Failure) Trial (2017) (47)
The 24-hour heart rate behavior in long-term survivors of cardiac transplantation. (1988) (46)
Impact of Cigarette Smoking in High-Risk Patients Participating in a Clinical Trial. A Substudy from the Heart Outcomes Prevention Evaluation (HOPE) Trial (2005) (45)
Left ventricular hypertrophy in hypertensive patients is associated with abnormal rate adaptation of QT interval. (1997) (45)
Comparison of the effects of exercise and posture on the baroreflex in man. (1971) (44)
Data-monitoring committees in clinical trials (1993) (44)
The action of clonidine on the baroreflex control of heart rate in conscious animals and man, and on single aortic baroreceptor discharge in the rabbit. (1975) (43)
Adaptation of hypertensives to treatment with cardioselective and non-selective beta-blockers. Absence of correlation between bradycardia and blood pressure control, and reduction in slope of the QT/RR relation. (1980) (42)
1989 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. (1989) (41)
Skeletal muscle metabolism in heart failure: a 31P nuclear magnetic resonance spectroscopy study of leg muscle. (1990) (41)
Variability of electrocardiographic and enzyme evolution of myocardial infarction in man. (1981) (41)
The reflex cardiovascular depression caused by occlusion of the coronary sinus in the dog (1972) (40)
Early and late changes in left ventricular filling after acute myocardial infarction and the effect of infarct size. (1992) (40)
Resting heart rate is associated with renal disease outcomes in patients with vascular disease: results of the ONTARGET and TRANSCEND studies (2015) (38)
The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: Results from the ONTARGET trial (2014) (38)
Selection of reperfusion therapy for individual patients with evolving myocardial infarction. (1997) (38)
New evidence on the importance of the renin–angiotensin system in the treatment of higher-risk patients with hypertension (2003) (38)
Quantitative index of baroreflex activity in normal and hypertensive subjects using Valsalva's manoeuvre. (1969) (38)
Results of the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial by geographical region (2005) (38)
Direct Arterial Pressure and Electrocardiogram during Motor Car Driving (1973) (37)
Effects of pulsed β-stimulant therapy on β-adrenoceptors and chronotropic responsiveness in chronic heart failure (1995) (36)
Time course of haemodynamic changes after maximal exercise (1994) (36)
Home telemonitoring of vital signs and cardiorespiratory signals in heart failure patients: system architecture and feasibility of the HHH model. (2007) (36)
Effect of low doses of scopolamine on RR interval variability, baroreflex sensitivity, and exercise performance in patients with chronic heart failure. (1996) (35)
BLOOD PRESSURES, HEARTS, AND U-SHAPED CURVES (1988) (35)
Effects of acute and chronic beta-adrenoceptor blockade on baroreflex sensitivity in humans. (1988) (33)
Diminished baroreflex sensitivity in high blood pressure and ageing man. (1969) (33)
Effects of Unilateral and Bilateral Carotid Baroreflex Stimulation on Cardiac and Neural Sympathetic Discharge Oscillatory Patterns (2003) (32)
Diurnal variations of QT interval after cardiac transplantation. (1988) (31)
Action potentials in afferent fibres from pericardial mechanoreceptors in the dog. (1965) (30)
Lack of peripheral modulation of cardiovascular central oscillatory autonomic activity during apnea in humans. (1997) (30)
Cigarette smoking, tar yields, and non-fatal myocardial infarction: 14000 cases and 32000 controls in the United Kingdom (1995) (30)
Role of the Baroreceptor Reflexes in Circulatory Control, With Particular Reference to Hypertension (1991) (30)
Serum potassium, cardiovascular risk, and effects of an ACE inhibitor: results of the HOPE study. (2005) (30)
The effects of raising alveolar PCO2 and ventilation separately and together on the sensitivity and setting of the baroreceptor cardiodepressor reflex in man (1974) (29)
Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation (2017) (29)
Interdependence of blood pressure and heart period regulation in mild hypertension. (1991) (29)
QT interval dynamics and heart rate variability preceding a case of cardiac arrest. (1997) (28)
What is hypertension? (1971) (28)
Book Review: ISAM 1979: Proceedings of the Third International Symposium on Ambulatory Monitoring (1981) (28)
Mechanisms concerned with blood pressure variability throughout the day. (1985) (27)
Current options in the management of coronary artery disease. (2003) (27)
Fortnightly Review: Short acting dihydropyridine (vasodilating) calcium channel blockers for hypertension: is there a risk? (1996) (27)
Glucose intolerance and diabetes as risk factors for cognitive impairment in people at high cardiovascular risk: results from the ONTARGET/TRANSCEND research programme. (2009) (27)
The relation of arterial pressure to sleep and arousal in man. (1967) (27)
Evolutionary pattern and prognostic importance of heart rate variability during the early phase of acute myocardial infarction. (2001) (27)
Hemodynamic effects of captopril and isosorbide mononitrate started early in acute myocardial infarction: a randomized placebo-controlled study. (1993) (27)
Clinical and haemodynamic correlates of heart rate turbulence as a non-invasive index of baroreflex sensitivity in chronic heart failure (2011) (26)
Continuous recording of direct arterial pressure and electrocardiogram in unrestricted man. (1972) (26)
Relative and Combined Prognostic Importance of On-Treatment Mean and Visit-to-Visit Blood Pressure Variability in ONTARGET and TRANSCEND Patients (2017) (26)
Evaluation of organ damage in hypertension. (1993) (25)
Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis (2021) (25)
The role of serum myoglobin in the detection and measurement of myocardial infarction. (1980) (25)
Beta blockade early in acute myocardial infarction. (1987) (25)
Cardiovascular risk factors and the effects of intervention. (1991) (24)
ISIS-3 and GISSI-2: no survival advantage with tissue plasminogen activator over streptokinase, but a significant excess of strokes with tissue plasminogen activator in both trials. (1993) (24)
Power Spectral Analysis of Heart Rate Variability and Baroreflex Gain: Author's Reply (1995) (24)
Neurophysiology of the carotid sinus receptors in normal and hypertensive animals and man. (1976) (24)
Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP) (2016) (24)
Ventricular arrhythmias in long term survivors of orthotopic and heterotopic cardiac transplantation. (1988) (24)
Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination, in high risk patients: The Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telm (2004) (24)
Cardioselective and nonselective beta-adrenoceptor blocking drugs in hypertension: a comparison of their effect on blood pressure during mental and physical activity. (1985) (23)
Cardiovascular effects of music by entraining cardiovascular autonomic rhythms music therapy update: tailored to each person, or does one size fit all? (2013) (22)
Platelet alpha-adrenoreceptors in borderline and established essential hypertension. (1983) (22)
How much should blood pressure be lowered? The problem of the J-shaped curve. (1989) (21)
Baroreflex sensitivity and the blood pressure response to β-blockade (1999) (21)
Reproducibility of heart rate variability indices during exercise stress testing and inotrope infusion in chronic heart failure patients. (1996) (21)
Impact of CKD on Household Income (2017) (20)
Continuous recording of direct arterial pressure in unrestricted patients-its role in the diagnosis and management of high blood pressure. (1975) (20)
Lipophilic versus hydrophilic β1 blockers and the cardiac sympatho-vagal balance during stress and daily activity in patients after acute myocardial infarction (1998) (20)
The HOPE study: comparison with other trials of secondary prevention. (2001) (20)
Cholesterol and coronary heart disease mortality. (1992) (20)
Assessment of cardiac autonomic excitability in renal hypertensive rabbits using clonidine-induced resetting of the baroreceptor-heart rate reflex. (1975) (20)
Arterial baroreceptors as determinants of 0.1hz and respiration-related changes in blood pressure and heart rate spectra (1997) (19)
The effects of hypoxia, hypercapnia, and asphyxia on the baroreceptor-cardiac reflex at rest and during exercise in man. (1972) (19)
Pathophysiological and clinical relevance of simplified monitoring of nocturnal breathing disorders in heart failure patients (2009) (19)
Alterations of breathing in chronic heart failure: clinical relevance of arterial oxygen saturation instability. (1996) (18)
Beta-adrenergic blockade after myocardial infarction. (1981) (18)
Effects of the angiotensin receptor blocker, telmisartan, on cardiovascular events in high-risk patients intolerant to ACE-inhibitors. Erratum of Vol 372(9644):1174-83 (2008) (18)
Cardiorespiratory interactions to external stimuli. (2005) (18)
Albuminuria and rapid loss of GFR and risk of new hip and pelvic fractures. (2013) (18)
Ambulatory pressure monitoring in the assessment of antihypertensive therapy (1989) (18)
Baroreflex sensitivity and the blood pressure response to beta-blockade. (1999) (18)
Diabetes clinical trials: helped or hindered by the current shift in regulatory requirements? (2012) (18)
Validation of the beat to beat measurement of blood velocity in the human ascending aorta by a new high temporal resolution Doppler ultrasound spectral analyser (1992) (18)
Assessment of the antihypertensive effect of atenolol with 24 h ambulatory monitoring of blood pressure. (1979) (17)
Frequency-dependent baroreflex control of blood pressure and heart rate during physical exercise. (2006) (17)
"Pixie" cardiography. Accelerometer applications to phonocardiography and displacement cardiography in childhood. (1971) (17)
The influence of ventilation, carbon dioxide and hypoxia on the baroreceptor reflex in man. (1968) (16)
1999 WHO/ISH Hypertension Guidelines--highlights & ESH Update. (2003) (16)
Scientific Foundations of Cardiology (1985) (16)
Heart rate and blood pressure interactions in the development of erectile dysfunction in high-risk cardiovascular patients (2014) (16)
Effect of atenolol or metoprolol on waking hour dynamics of the QT interval in myocardial infarction. (1998) (16)
Use of beta adrenoceptor blockade during and after acute myocardial infarction. (1986) (16)
Heart rate and ectopic prematurity in relation to sustained ventricular arrhythmias. (1980) (16)
IS A SLOW PULSE-RATE A RELIABLE SIGN OF DIGITALIS TOXICITY? (1978) (16)
Nocturnal periodic breathing is an independent predictor of cardiac death and multiple hospital admissions in Heart failure (2006) (16)
Cardiovascular variability is/is not an index of autonomic control of circulation. (2006) (15)
Where are clinical trials going? Society and clinical trials (2004) (15)
Should post-infarction asymptomatic ventricular arrhythmias be treated? The need for caution. (1995) (15)
Low resting heart rates are associated with new‐onset atrial fibrillation in patients with vascular disease: results of the ONTARGET/TRANSCEND studies (2015) (15)
Changes in baroreflex sensitivity at the transitions between rest and exercise. (1969) (15)
Speed of action of aspirin, soluble aspirin, and buffered aspirin. (1960) (15)
Impact of telmisartan on cardiovascular outcome in hypertensive patients at high risk: a Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease subanalysis (2014) (14)
EFFECT OF ATENOLOL ON RECOVERY OF THE ELECTROCARDIOGRAPHIC SIGNS OF MYOCARDIAL INFARCTION (1979) (14)
Methodology of baroreflex testing. (1992) (14)
Atrial septostomy. (1968) (14)
Effects on ventricular arrhythmias of oral captopril and of oral mononitrate started early in acute myocardial infarction: results of a randomised placebo controlled trial. (1993) (14)
UNILATERAL ELEVATION OF THE INTERNAL JUGULAR PULSE (1962) (14)
Progress and problems for randomized clinical trials: from streptomycin to the era of megatrials. (2006) (13)
1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension endorsed by the Lebanese Hypertension League (1999) (13)
Statistical analysis of the 24 hour blood pressure using pressure frequency histograms. (1976) (13)
The use of 24 hour blood pressure monitoring in the diagnosis and management of difficult hypertensive problems. (1976) (13)
Clinical evidence from ONTARGET: the value of an angiotensin II receptor blocker and an angiotensin-converting enzyme inhibitor (2009) (13)
The influence of arterial baroreceptors in man on the variability of blood pressure and plasma catecholamines in man. (1983) (13)
The Variability of Arterial Pressure (1979) (13)
Primary prevention of coronary heart disease in hypertension (1996) (12)
The renin-angiotensin system: a review of trials with angiotensin-converting enzyme inhibitors and angiotensin receptor blocking agents (2002) (12)
Isolated systolic hypertension: cardiovascular risk and treatment benefits. (2001) (12)
Cardiovascular protection for all individuals at high risk: evidence-based best practice (2008) (12)
Effects of pulsed beta-stimulant therapy on beta-adrenoceptors and chronotropic responsiveness in chronic heart failure. (1995) (12)
Reperfusion in acute myocardial infarction (2005) (12)
Hyponatremia and Ultramarathons (1986) (12)
Arterial baroreflexes can determine long‐termblood pressure (2004) (11)
Trandolapril Review of its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Use in Essential Hypertension (1994) (11)
Long-term time-course of nocturnal breathing disorders in heart failure patients (2009) (11)
Cardiac vomiting. (1981) (11)
Differences between casual and 24-h blood pressures. (1985) (11)
Arterial baroreflexes can determine long-term blood pressure. Baroreceptors and hypertension: time for a re-think? (2004) (11)
Reperfusion in acute myocardial infarction. International Society and Federation of Cardiology and World Health Organization Task Force on Myocardial Reperfusion. (1994) (11)
Early intravenous beta-blockade in myocardial infarction. (1982) (11)
Is there an age limit for thrombolytic therapy? (1993) (10)
The sympathetic nervous system in hypertension: differing effects of drug treatment. (1998) (10)
Provision of services for the diagnosis and treatment of heart disease in England and Wales. Third report of a Joint Cardiology Committee. Royal College of Physicians of London and the Royal College of Surgeons of England. (1985) (10)
Teaching communication skills: part of medical education? (1995) (10)
SAFETY AND EFFICACY OF AGGRESSIVE BLOOD PRESSURE LOWERING AMONG PATIENTS WITH DIABETES: SUBGROUP ANALYSES FROM THE ONTARGET TRIAL (2009) (10)
Safety of Perioperative Aprotinin Administration During Isolated Coronary Artery Bypass Graft Surgery: Insights From the ART (Arterial Revascularization Trial) (2018) (10)
Baroreflex sensitivity and heart rate variability as predictors of cardiovascular outcome in hypertensive patients with multiple risk factors for coronary disease (2001) (10)
Baroreflex control of blood pressure and plasma noradrenaline during exercise in essential hypertension. (1979) (10)
Haemodynamic Changes During Sleep in Man (1982) (10)
Enthusiasm, reality, and cost-effectiveness analysis (1998) (10)
A multi-country randomised trial of the role of a new telemonitoring system in CHF: the HHH study (Home or Hospital in Heart Failure). Rational, study design and protocol (2004) (9)
THE DIAGNOSIS AND TREATMENT OF AORTIC STENOSIS COMPLICATED BY HEART BLOCK (1965) (9)
The Lability of Blood Pressure (1982) (9)
Case reportOrthostatic hypertension (1979) (9)
Impaired control of heart rate leads to increased blood pressure variability. (1984) (9)
Do we need to intervene after thrombolysis in acute myocardial infarction? (1990) (9)
THE RELEVANCE OF BAROREFLEX MECHANISMS TO THE CONTROL OF AMBULATORY AND EXERCISE BLOOD PRESSURE IN HUMANS (1989) (9)
Thrombolysis: state of the art. (1993) (9)
Enoxaparin versus unfractionated heparin in ST-elevation myocardial infarction. (2006) (9)
Baroreceptor firing frequency and activation of carotid sinus vascular smooth muscle in dogs [proceedings]. (1978) (8)
Proposals for a new training programme for cardiology. Joint Training and Manpower Group representing the Specialty Advisory Committee and the Cardiology Committee of the Royal College of Physicians of London, and the British Cardiac Society. (1990) (8)
Pain relief in acute myocardial infarction by intravenous atenolol (1981) (8)
Sympathetic stimulations by exercise-stress testing and by dobutamine infusion induce similar changes in heart rate variability in patients with chronic heart failure. (1995) (8)
Global differences in blood pressure control and clinical outcomes in the INternational VErapamil SR‐Trandolapril Study (INVEST) (2005) (8)
The measurement of arterial pressure, carotid sinus radius and baroreflex sensitivity in the conscious greyhound [proceedings]. (1979) (8)
The role of angiotensinconverting enzyme inhibitors in the treatment of hypertension (2001) (8)
Importance of cardiovascular reflexes in disease. (1988) (8)
Cardiac and blood pressure responses to mental stress in reactive hypertensives. (1991) (8)
Changes in the baroreceptor-cardiac reflex in exercise. (1969) (7)
STREPTOKINASE IS STILL THE AGENT OF CHOICE FOR MOST PATIENTS WITH MYOCARDIAL INFARCTION (1995) (7)
Lowering of blood pressure and artery stiffness (1997) (7)
Isis-4 pilot study: Serial hemodynamic changes with oral captopril and oral isosorbide mononitrate in a randomized double-bund trial in acute myocardial infarction (1991) (7)
Effect of Long-Term, Once-Daily Administration of Atenolol, Metoprolol, Pindolol and Slow-Release Propranolol on Ambulatory Blood Pressure and its Variability (1982) (7)
Effects of long-term, once-daily administration of atenolol on ambulatory blood pressure of hypertensive patients. (1981) (7)
Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis (2022) (7)
Vasodilators after myocardial infarction-ISIS IV. (1994) (7)
Hemodynamics in hypertension and heart failure. (1984) (7)
Decrease in baroreflex sensitivity with increasing arterial pressure and with increasing age. (1969) (7)
Blood pressure variability in patients on beta-blockers. (1976) (6)
Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease (2019) (6)
Short term and long term effects of alcohol on blood pressure, cardiovascular risk and all cause mortality. (1996) (6)
Effect of once-daily atenolol on ambulatory blood pressure. (1979) (6)
Effect of different interventions on heart rate variability after heart transplantation: non-autonomic vs autonomic factors. (1996) (6)
ATENOLOL, HEPARIN AND THE INTERMEDIATE CORONARY SYNDROME (1981) (6)
Clinical trial of the beta-adrenoreceptor-blocking agent tolamolol with the use of 24 hour blood pressure recordings. (1976) (6)
Hypertrophy at ECG and its regression during treatment survey (HEART survey). Rationale, design and baseline characteristics of patients. (2003) (6)
Professor Peter Sleight's reflections on the use of beta-blocking agents after myocardial infarction. (1997) (6)
Circadian Variation and Waking Hour Dynamics of the QT Interval (1997) (6)
Proceedings: The effects of mild hypoxia with constant PA, C02 and ventilation on the setting and sensitivity of the baroreceptor-cardiac-depressor reflex in man. (1973) (6)
High blood pressure: what level to treat? (1985) (6)
Assessment of pulmonary ventilation scans using xenon-127 in the diagnosis of pulmonary embolism (2004) (6)
What happened to intravenous atenolol in acute myocardial infarction? (1994) (6)
REDUCTION IN INFARCT SIZE, MORBIDITY AND SHORT-TERM MORTALITY BY EARLY INTRAVENOUS BETABLOCKADE (1983) (6)
Lipid screening in aircrew: pros and cons. (1992) (6)
Calcium antagonists and cardiovascular prognosis: a homogeneous group? (1996) (6)
Isolated systolic hypertension : the WISHE study (1999) (6)
Skeletal muscle metabolism in experimental heart failure: Effects of infarct size and physical training (1991) (6)
New methods for risk stratification in patients after myocardial infarction autonomic control and substrate sensitivity. (2007) (5)
Non-invasive baroreflex testing should be used to assess prognosis. (2000) (5)
ADVANTAGES AND DISADVANTAGES OF THE META-ANALYSIS APPROACH. DISCUSSION (1996) (5)
No HOPE without proof: do ARBs meet the standard for cardiovascular protection? (2008) (5)
PPOGRESS beyond HOPE and LIFE: The ONTARGET trial programme (2003) (5)
Phosphorus Magnetic Resonance Spectroscopy of Leg Muscle in Heart Failure (1989) (5)
The physiology of heart-rate control by arterial baroreceptors in man and animals (1980) (5)
Cardiac benefits of ACE inhibitors and calcium antagonists alone and in combination. (1994) (5)
Baroreflex sensitivity and plasma noradrenaline concentration in relation to the blood pressure during dynamic exercise in hypertension [proceedings]. (1979) (5)
Future perspectives and implications. (2001) (5)
A multi-country randomised trial of the role of a new telemonitoring system in CHF: the HHH Study (Home or Hospital in Heart Failure). Preliminary data (2005) (4)
AFTER ISIS-3 - REPLY (1992) (4)
We could all learn from the Italian cardiologists. (2004) (4)
Holter monitoring of ventricular arrhythmias in a randomised, controlled study of intravenous streptokinase in acute myocardial infarction. (1991) (4)
[Rehabilitation and models of domiciliary care of patients with chronic heart failure: preliminary results of the HHH study]. (2005) (4)
Reduction in Infarct Size, Arrhythmias, Chest Pain and Morbidity by Early Intravenous β-Blockade in Suspected Acute Myocardial Infarction (2012) (4)
Orthostatic hypertension. (1979) (4)
Treatment of chronic heart block with the Lucas induction coil pacemaker. (1971) (4)
Oxford and McKinsey: Cogwheel and beyond. (1970) (4)
Ramipril prevents major cardiovascular events in high-risk women: results of the HOPE trial (2002) (4)
Ambulatory Blood Pressure and its Variability During Randomised Double-blind Administration of Atenolol, Metoprolol, Pindolol and Long Acting Propranolol in Subjects with Mild to Moderate Hypertension (1983) (4)
European Society of Hypertension Scientific Newsletter, Update on Hypertension Management: Treatment of hypertension in patients with type‐2 diabetes mellitus (2000) (4)
The effect of raising arterial blood pressure on ventilation in man. (1969) (4)
Angiotensin II and trials of cardiovascular outcomes. Discussion (2002) (4)
Ambulatory blood pressure monitoring. (1985) (4)
S12. Music and the autonomic nervous system S12.1 Dynamic interactions between musical, cardiovascular and cerebral rhythms in man (2009) (4)
Trials and tribulations: the ISIS experience. (1992) (3)
A historical perspective on peripheral reflex cardiovascular control from animals to man (2014) (3)
The effect of mental arithmetic on blood pressure variability and baroreflex sensitivity in man [proceedings]. (1978) (3)
Session I. Nervous Anatomy and Physiology of Cardiovascular Control and Orthostatic Regulation (1976) (3)
The effects of changing ventilation and alveolar CO 2 , separately and together, on the baroreceptor-cardio-depressor reflex in man. (1972) (3)
Ascending aortic Doppler velocity and the prediction of exercise capacity in post-infarction left ventricular dysfunction. (1992) (3)
Comments on the MRC/BHF Heart Protection Study (2003) (3)
Nonpharmacological treatments for hypertension. (2012) (3)
Dissection of the Aorta with Pericardial Tamponade: Successful Relief of Tamponade (1965) (3)
14 Physical training and ambulatory and sleep blood pressures in borderline hypertensive patients (1988) (3)
REDUCTION IN INFARCT SIZE, ARRHYTHMIAS AND MORBIDITY BY EARLY INTRAVENOUS BETA BLOCKADE (1982) (3)
What is hypertension? Recent studies on neurogenic hypertension (3)
The cardiovascular effects of coronary sinus distension in the anaesthetised dog. (1972) (3)
New Trial Data on Prevention: Potassium and CV Risk in Hope (2003) (3)
Are antianginal drugs effective in post-myocardial infarction secondary prevention? (1995) (3)
"Type B" cardiology. (1982) (3)
SYMPOSIUM ON HYPERTENSION IN THE ELDERLY THE EFFECT OF AGEING ON THE CIRCULATION (1979) (3)
Supraventricular tachycardia after heterotopic heart transplantation. (1988) (3)
RANDOMIZED TRIAL OF HIGH-DOSE INTRAVENOUS STREPTOKINASE, OF ORAL ASPIRIN, AND OF INTRAVENOUS HEPARIN IN ACUTE MYOCARDIAL-INFARCTION (1987) (3)
Changes in the sensitivity of the baroreflex in muscular exercise. (1970) (3)
ISIS-4 (1995) (3)
Survival following thrombolytic therapy. (1990) (3)
Long-term monitoring of sleep apnea at home in heart failure patients: preliminary results from the HHH study (2004) (3)
The diagnosis of hypertension. (1971) (3)
Beta-blockade in acute myocardial infarction. (1982) (3)
A new telemonitoring system in heart failure. Preliminary data from the multi-country randomized study HHH (Home or Hospital in Heart failure) (2006) (3)
Thrombolysis in Acute Myocardial Infaction: Lessons from ISIS‐2 (1988) (3)
Medical Interventions in Acute Myocardial Infarction (1990) (3)
ISIS-4 - REPLY (1995) (3)
Blood Pressure and Heart Rate Variability (1983) (3)
Mechanisms for the early mortality reduction produced by beta blockade in acute myocardial infarction (1988) (3)
After the diagnosis of systemic hypertension, is risk factor management important? (1992) (2)
FLASH PULMONARY EDEMA (FPE) AND BILATERAL RENAL ARTERY STENOSIS (RAS) - THE PICKERING SYNDROME - A HYPERTENSIVE EMERGENCY: HT.3.06 (2010) (2)
Hypertrophic cardiomyopathy. (1968) (2)
Baroreflex control of stroke volume: A vagal mediated effect (1991) (2)
The heart rate-independent effects of inotropic stimulation and afterload augmentation on atrial performance (1991) (2)
Inequalities in health in Britain: specific explanations in three Lancashire towns (1987) (2)
Cholesterol and total mortality (1992) (2)
Carotid baroceptor re-setting in the hypertensive dog. (1975) (2)
Pain Relief, General Management, and Other Adjunctive Treatments (2007) (2)
ISIS-2 - A LARGE RANDOMIZED TRIAL OF INTRAVENOUS STREPTOKINASE AND ORAL ASPIRIN IN ACUTE MYOCARDIAL-INFARCTION (1989) (2)
Investigating modifications to participant information materials to improve recruitment into a large randomized trial (2019) (2)
The Management of acute myocardial ischaemia (1990) (2)
Calcium Antagonists During and After Myocardial Infarction (1996) (2)
Smoking and ischaemic heart disease. Overview. (1999) (2)
Blood pressure levels for treatment of uncomplicated diabetes in primary care. (2013) (2)
The baroreflex bandwagon: time to get off? (2001) (2)
Beating heart disease (2005) (2)
SAFETY AND EFFICACY OF LOW BLOOD PRESSURE AMONG PATIENTS WITH DIABETES: SUB-GROUP ANALYSES FROM THE ONTARGET TRIAL: 7E.02 (2011) (2)
Prevention of coronary heart disease and hypertension. (1988) (2)
Treatment of hypertension in patients with type-2 diabetes mellitus. (2000) (2)
BLOOD PRESSURE TARGETS RECOMMENDED BY GUIDELINES AND INCIDENCE OF CARDIOVASCULAR AND RENAL EVENTS IN THE ONTARGET TRIAL: 9A.08 (2011) (2)
Early Intravenous Atenolol in Suspected Acute Myocardial Infarction: Final Report of a Randomised Clinical Trial (1984) (2)
Session IV. Therapy of Orthostatic Disturbances (1976) (2)
Placebo-controlled, cross-over trial of physical training, lisinopril and the combination in moderate to severe heart failure (1991) (2)
Wider inclusion criteria needed for thrombolytic therapy. (1989) (2)
The influence of mortality trials on the evolution of clinical practice. (1994) (2)
Predictors of blood pressure control in the convince trial (2004) (2)
MRC/BHF Heart protection study. Authors' reply (2002) (1)
Proceedings: Simultaneous recording of the carotid sinus dimensions and the baroreptor nerve in the anaesthetized dog. (1975) (1)
Stress Factors in Angina Pectoris (1977) (1)
Beta-adrenoceptor blockade in the treatment of coronary heart disease. (1986) (1)
ISIS-3 - REPLY (1991) (1)
CORRESPONDENCF SECTION Platelet a-adrenoreceptors in borderline and established essential hypertension (1983) (1)
The secondary prevention of myocardial infarction by drug treatment; excluding lipid lowering agents. (1992) (1)
Proceedings: Effects of clondine on baroreflex arc in conscious rabbits and man. (1975) (1)
Telmisartan in high-risk patients intolerant of ACE inhibitors – Authors' reply (2009) (1)
Effect of Maximal Voluntary Exercise on Blood Pressure (1985) (1)
Continuous Blood Pressure Measurement (1982) (1)
Outcomes with physician's choice of initial drug in convince (2004) (1)
Lowering of blood pressure and artery stiffness (1997) (1)
Who is fooling us? (2002) (1)
THE DIAGNOSISAND TREATMENTOF AORTICSTENOSIS COMPLICATEDBY HEART BLOCK (1965) (1)
A Doppler derived index of diastolic function; Independent of preload, heart rate and atrio-ventricular interval (1990) (1)
Clinical Perspective on Risk Stratification (1997) (1)
Is cardioprotection important in the treatment of hypertension? Considerations for the ideal agent. (1993) (1)
Randomized trial of cholesterol-lowering and antioxidant vitamins in 7,000 high-risk individuals with LDL cholesterol below 120 mg/dl (2002) (1)
Preventing stroke with ramipril—authors' reply (2003) (1)
Is angiotensin a prime factor in blood pressure control? (1982) (1)
False negative total mortality results in cholesterol-lowering trials (1993) (1)
Severe paroxysmal hypertension induced by a subconscious Valsalva-like manoeuvres (1992) (1)
Evidence for Abnormalities Unrelated to Blood Flow (2005) (1)
Early intravenous beta-adrenoceptor blockade for victims of heart attack. (1988) (1)
Smoking and Ischaemic Heart Disease (1999) (1)
Overutilization and underutilization of thrombolysis in routine clinical practice. (2001) (1)
Cardiovascular medicine -- acute myocardial infarction : the importance of magnesium as a pharmacological agent : proceedings of a symposium held at the 5th European Magnesium Congress, Vienna, Austria, June 16, 1995 (1996) (1)
New analyses of Heart Protection Study (2004) (1)
Entry Clinical and ECG Variables Predictive of Eventual Infarct Size and Mortality in Patients with Suspected Myocardial Infarction (1983) (1)
Proceedings: Assessment of value of catheter biopsy of the heart. (1974) (1)
The effect of ageing on the circulation. (1979) (1)
Chlorthalidone significantly reduces the risk of stroke, congestive heart failure, coronary revascularization, and angina in high-risk hypertensive patients (2000) (1)
Factors associated with in-hospital death from myocardial infarction. (1997) (1)
hypothesis of instability of the chemoreflex loop Periodic breathing in heart failure patients: testing the (2015) (1)
Continuous recording of arterial pressure and electrocardiogram in unrestricted patients. (1972) (1)
AMBULATORY BLOOD-PRESSURE (1981) (1)
Blood pressure and cardiovascular risk in the HOPE study (2002) (1)
[The HOPE Study. What does it contribute to general practice?]. (2000) (1)
The Oxford years--the last of the Quarto! (2007) (1)
Music and the heart. (2015) (1)
Methodological aspects: general discussion (1996) (1)
When and how far should we lower blood pressure? (1983) (1)
Heart protection study. Authors' reply (2003) (1)
Cheyne-Stokes respiration during awake day-time in chronic heart failure: prognostic implication (1998) (1)
A Quantitative Assessment of Baroreceptor Reflex Sensitivity in Man, Awake and Asleep. (1968) (1)
Limitation of myocardial infarct size. Present status. (1983) (1)
72 Heart Rate Variability 20 Alterations of breathing in chronic heart failure : clinical rilevance of arterial oxygen saturation instability (1)
Myocardial infarction and hypertension links and interactions : proceedings of a satellite symposium to the 17th Congress of the European Society of Cardiology, Amsterdam, The Netherlands, August 20, 1995 (1996) (0)
Home telemonitoring of breathing disorders in chronic heart failure patients: the novel perspective of the HHH project (2004) (0)
Publication of clinical trial results: a clinical investigator's view. (1995) (0)
Latest European guidelines for the treatment of hypertension (2013) (0)
CONCLUDING REMARKS ON REFLEX CONTROL OF THE CIRCULATION IN MAN (1981) (0)
Physiology 2014: An insider’s view (2014) (0)
Optimizing treatment after myocardial infarction now and in the future (1997) (0)
, Janice and Stroke in Patients With Coronary Artery Disease Systolic and Diastolic Blood Pressure Changes in Relation With Myocardial Infarction (2014) (0)
Small versus large cardiovascular trials (1990) (0)
Regression of left ventricular hypertrophy and its effect on cardiovascular morbidity and mortality (2003) (0)
Session II. Physiopathology and Clinical Aspects of Cardiovascular Dysregulation, Especially Orthostatic (1976) (0)
Adaptation ofhypertensives totreatmentwith cardioselective andnon-selective beta-blockers Absence ofcorrelation between bradycardia and (1980) (0)
Music and the heart. (2015) (0)
REFLEX CARDIAC ARREST IN TETRAPLEGIA (1976) (0)
PRIMARY PREVENTION OF CORONARY HEART DISEASE IN HYPERTENSION. DISCUSSION (1996) (0)
Effect of beta-blockers on arrhythmias. (1979) (0)
The future of cardiology and psychogeriatrics (1981) (0)
Defects in Signal Generation in Arterial Baroreceptors (1984) (0)
Peter Joseph Wilkinson Monks (2017) (0)
Factors in the choice of beta-blocker vs. diuretic for initial treatment of hypertension in convince (2004) (0)
Lisinopril Review of its Pharmacology and Clinical Efficacy in Elderly Patients (1997) (0)
ATRIAL SEPTOSTOMY BY BALLOON CATHETER (1967) (0)
Effects of Infarct size and Exercise Training on Skeletal Muscle Metabolism in Experimental Heart Failure (1991) (0)
Dilemmas in hypertension and care of the coronary patient (1988) (0)
1128-120 Importance of an oral glucose tolerance test in identifying high prevalence of dysglycemia in individuals at high cardiovascular risk (2004) (0)
679 Predictive value of increased body weight and abdominal adiposity for cardiovascular events in high-risk patients a sub-study of the ontarget/transcend trials (2011) (0)
Coronary Circulation and Myocardial Ischaemia: Thrombolysis (2002) (0)
Aortic Blood Acceleration Correlates Well with Ejection Fraction Post Infarction (1989) (0)
New analyses of Heart Protection Study - Reply (2004) (0)
Normalization of the Ecg in Survivors of Myocardial Infarction on β-Adrenoreceptor-Blocking Agents (1979) (0)
Incidence of MI is equivalent with verapamil SR-based and atenolol-based strategies in patients with hypertension and CAD: the international verapamil SR-trandolapril study (2004) (0)
Beta-blockers in immediate treatment of myocardial infarction (1980) (0)
Abstract 1305: Erectile Dysfunction Predicts Cardiovascular Events in High Risk Patients Receiving Telmisartan, Ramipril or Both (2009) (0)
Randomized trial of cholesterol-lowering, and of antioxidant vitamins, in 6,000 people with diabetes mellitus (2002) (0)
Contents, Vol. 84, 1994 (1994) (0)
Morbidity and mortality reduction with ramipril: The latest results of the HOPE trial (2000) (0)
Blood pressure analyses from 25 595 patients (from 25 620 randomised) during the ONTARGET trial: reflections on current guidelines (2008) (0)
The innovative approach of the HHH project to detect cardiorespiratory signals in chronic heart failure patients (2004) (0)
Regular coffee consumption increased mean 24-hour ambulatory blood pressure in older men and women (1999) (0)
Continuous B.P. and E.C.G. Recording (1972) (0)
Ramiprilof its Use in the Prevention of Cardiovascular Outcomes (2002) (0)
Circadian Variability in QT Interval Dynamics: Implications for Mechanisms Underlying Sudden Cardiac Death (1996) (0)
Environmental factors in circulatory control. (1982) (0)
Computerized analysis of ambulatory monitoring in the quantification of sinoatrial disease (1994) (0)
Limitation of Myocardial Infarct Size (1983) (0)
The Effect of Physical Fitness on Resting Intra-Arterial Blood Pressure (1986) (0)
Ventricular arrhythmias inlongtermsurvivors of orthotopic andheterotopic cardiac transplantation (1988) (0)
Karatzas , Hamill , and Sleight 2 (2003) (0)
[The noninvasive demonstration of functional reinnervation after heart transplantation]. (1994) (0)
Sleep revisited. (2000) (0)
24 Hour Changes in Heart Rate of the Transplanted and Innervated Human Hearts (1984) (0)
[Authors' reply] Telmisartan in high-risk patients intolerant of ACE inhibitors (2009) (0)
Value ofelectrocardiogra m inpredicting andestimating infarct sizeinman (1979) (0)
Blood Pressure Control During Mental Stress (1984) (0)
Thrombolysis in acute myocardial infarction (1989) (0)
METHODOLOGICAL ASPECTS : GENERAL DISCUSSION. DISCUSSION (1996) (0)
Comparison of Transthoracic Echocardiography Versus Cardiovascular Magnetic Resonance Imaging for the Assessment of Ventricular Function in Adults After Atrial Switch Procedures for Complete Transposition of the Great Arteries (2004) (0)
Verdi is in tune when it comes to blood pressure control. (2010) (0)
Interventions During and After Acute Myocardial Infarction (2012) (0)
P-334: Gender differences in carotid sinus baroreceptor reflexes in healthy young normal subjects and in ASCOT patients with treated essential hypertension (2002) (0)
Controlled trial of physical training in moderate to severe heart failure (1990) (0)
OVERVIEW OF MORTALITY RESULTS FROM ALL RANDOMIZED CONTROLLED TRIALS OF EARLY IV BETA-BLOCKADE AFTER MYOCARDIAL-INFARCTION (1986) (0)
Diabetes status and fasting plasma glucose are independent determinants of cognitive status in people at high risk for cardiovascular disease (2006) (0)
Non-Invasive Haemodynamic Assessment of Reactive Hypertensives during Mental Arithmetic (1988) (0)
Absence of Relation between Severity of Myocardial Infarction and Ventricular Arrhythmias (1978) (0)
The influence of systolic pressure and pulse pressure on baro reflex sensitivity in man abstract (1968) (0)
Emerging Clinical Applications of Ambulatory Blood Pressure Recording (1993) (0)
Chronic Coronary Artery Disease Predictors of Adverse Outcome Among Patients With Hypertension and Coronary Artery Disease (2006) (0)
Abstract 2562: Fasting Plasma Glucose is an Independent Predictor of Hospitalization for Congestive Heart Failure in High-Risk Patients (2006) (0)
ISIS COLLABORATIVE GROUP - RANDOMIZED TRIAL OF EARLY IV ATENOLOL IN MYOCARDIAL-INFARCTION - SUBSIDIARY ANALYSES (1986) (0)
Subject Index, Vol. 84, 1994 (1994) (0)
Further evidence from ONTARGET: additional vascular protection (2009) (0)
Modulation of blood pressure throughout the day by the baro reflexes (1983) (0)
Effects of cholesterol-lowering therapy and antioxidant vitamin supplementation on the risk of stroke (2002) (0)
Antiarrhythmic Properties of Beta-Adrenoceptor Blockade During and After Myocardial Infarction (1989) (0)
[Effect of atenolol on the QT interval in the acute phase of myocardial infarction]. (1988) (0)
Cardiovascular Research – the first 25 years (1991) (0)
INFARCTION: FINAL REPORT OF A RANDOMISED CLINICAL TRIAL (1984) (0)
[Diurnal rhythm of the QT interval in healthy persons]. (1987) (0)
Early Intravenous β-adrenoceptor blockade for victims of heart attack Peter Sleight (1988) (0)
Glucose intolerance and diabetes as risk factors for cognitive impairment in people at high cardiovascular risk: results from the ONTARGET/TRANSCEND (2009) (0)
Nocturnal angina. (1972) (0)
Introduction (1994) (0)
Randomized trial of cholesterol-lowering and antioxidant vitamins in 5,000 women at high-risk of coronary heart disease (2002) (0)
Treating senile orofacial dyskinesia (1982) (0)
Autumn Books: Longevity's legacy (1985) (0)
Cardiovascular Benefits of Antihypertensive Therapy Postacute Myocardial Infarction (2012) (0)
Exercise and the heart. (1992) (0)
472 Feasibility of home telemonitoring of vital signs and cardiorespiratory signals in chronic heart failure patients: preliminary results from the HHH study (2005) (0)
Graded Dynamic Exertion Progressively Increases Plasma Concentrations of Atrial Natriuretic Peptide (ANP) in Normal Man (1987) (0)
Ramipril Global Endpoint Trial / Telmisartan Randomized AssessmeNt Study in ACE withTelmisartan , Ramipril , or Both : The ONgoing Telmisartan Alone and in combination Erectile Dysfunction Predicts Cardiovascular Events in High-Risk Patients Receiving (2010) (0)
Physiological Aspects of Blood Pressure Measurement (1977) (0)
Clinical use of beta blockers in hypertension. (1981) (0)
G54: Non-invasive hemodynamics of white coat hypertensives (1997) (0)
Effects of atropine and propranolol on baroreflex in man during rest and exercise. (1970) (0)
Focus on thrombolytic therapy. (1997) (0)
Dangers of thrombolysis. (1990) (0)
Occasional survey Cardiac vomiting (0)
Blood pressure variability in patients on beta-blockers. (1976) (0)
Are we underestimating the risk of hypertension by the use of too few BP estimations (1990) (0)
Skeletal Muscle Metabolism in Steady State and Incremental Exercise in Heart Failure using 31P Magnetic Resonance Spectroscopy (1986) (0)
Health Services and Outcomes Research Influenza Vaccination and Major Adverse Vascular Events in High-Risk Patients (2012) (0)
Is arterial baroreflex control of blood pressure and heart period active during physical exercise (1994) (0)
Evolution and Prediction of Infarct Size after Acute Myocardial Infarction in Man (1978) (0)
Heart rateandectopic prematurity inrelation tosustained ventricular arrhythmias (1980) (0)
Prevalence and persistence of breathing disorders in chronic heart failure patients: preliminary results from home telemonitoring in the HHH study (2005) (0)
Session III. Clinical Aspects of Orthostatic Dysregulation (1976) (0)
The concept of essential hypertension. (1972) (0)
Letter: Reflex cardiac arrest in tetraplegia. (1976) (0)
Loaddependence ofchanges inforearm andperipheral vascular resistance after acutelegexercise inman (2011) (0)
The risk of stroke after thrombolytic therapy. (1992) (0)
Effect of vagal stimulation by scopoderm TTS on exercise performance and R-R interval variability (RRV) in patients with chronic heart failure (CHF) (1993) (0)
Ischaemic Heart Disease and Exercise. Edited by R. J. Shephard. Pp. 428. (Croom Helm, London, 1981.) £19.95 (1982) (0)
Reduction in infarct size and morbidity by early intravenous betablockade (1981) (0)
A cardiovascular depressor reflex elicited by occlusion of the coronary sinus in the dog. (1967) (0)
A Cross-Over Comparison of Outpatient Physical Training versus Rest in the Treatment of Moderate to Severe Heart Failure (1989) (0)
Effect of Long‐Term, Once‐Daily Administration of Atenolol on Ambulatory Blood Pressure of Hypertensive Patients (1981) (0)
Angiotensin Antagonism Effect of Long-Term Therapy With Ramipril in High-Risk Women (2016) (0)
332 Nocturnal periodic breathing oxygen desaturations and mortality in heart failure patients (2008) (0)
Workshop IV: Teaching communication in medical schools. (1995) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Professor Peter Sleight?

Professor Peter Sleight is affiliated with the following schools:

Professor Peter Sleight's Academic­Influence.com Rankings

Why Is Professor Peter Sleight Influential?

Professor Peter Sleight's Published Works

Published Works

What Schools Are Affiliated With Professor Peter Sleight?

Professor Peter Sleight's AcademicInfluence.com Rankings